MDPI and ACS Style
Ahi, M.; Hamidi Farahani, R.; Basiri, P.; Karimi Rahjerdi, A.; Sheidaei, A.; Gohari, K.; Rahimi, Z.; Gholami, F.; Moradi, M.; Ghafoori Naeeni, F.;
et al. Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial. Vaccines 2022, 10, 1800.
https://doi.org/10.3390/vaccines10111800
AMA Style
Ahi M, Hamidi Farahani R, Basiri P, Karimi Rahjerdi A, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Moradi M, Ghafoori Naeeni F,
et al. Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial. Vaccines. 2022; 10(11):1800.
https://doi.org/10.3390/vaccines10111800
Chicago/Turabian Style
Ahi, Mohammadreza, Ramin Hamidi Farahani, Pouria Basiri, Ahmad Karimi Rahjerdi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Milad Moradi, Farzad Ghafoori Naeeni,
and et al. 2022. "Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial" Vaccines 10, no. 11: 1800.
https://doi.org/10.3390/vaccines10111800